African countries established COVID-19 testing in one month: Here's how they did it
Afr. j. lab. med. (Online)
; 10(1): 1-6, 2021.
Artigo
em Inglês
| AIM (África)
| ID: biblio-1353359
Biblioteca responsável:
CG1.1
ABSTRACT
Background:
As a novel and deadly acute respiratory syndrome, which later became known as coronavirus disease 2019 (COVID-19), spread beyond China in late January 2020, there were no laboratories in Africa that could test for the disease. However, in early March, just over a month later, 42 African countries had developed the expertise and resources to perform COVID-19 testing. Our goal was to document this public health success story, learn from it, and use it to inform future public health action. Intervention Three groups were primarily responsible for establishing COVID-19 testing capacity in Africa. The first group comprised early test manufacturers who reacted with incredible speed and ingenuity early in the pandemic, such as the German company TIB MolBiol that developed a molecular test for COVID-19 before the SARS-CoV-2 genome sequence was available. The second group included private and public donors such as the Jack Ma Foundation, and the last were the coordinators of the rollout, such as the World Health Organization and the Africa Centres for Disease Control and Prevention (CDC). Lessons learnt The first lesson was that speed is critical, especially during a crisis. It was also demonstrated that being a predictable and transparent trusted institution opens doors and improves effectiveness. Africa CDC, which was only three years old, was able to secure significant resources from external partners and rapidly build substantial testing capacity within Africa because it is a trusted institution.Recommendations:
Low- and middle-income countries must build local trusted institutions to better prepare for public health challenges
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Saúde e Bem-Estar
/
ODS3 - Meta 3.3 Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis
/
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Meta 3.8 Atingir a cobertura universal de saúde
/
COVID-19
/
Pneumonía
/
Outras Doenças Respiratórias
Base de dados:
AIM (África)
Assunto principal:
Serviços Laboratoriais de Saúde Pública
/
Teste para COVID-19
/
COVID-19
Tipo de estudo:
Estudo diagnóstico
Limite:
Feminino
/
Humanos
/
Masculino
País/Região como assunto:
África
Idioma:
Inglês
Revista:
Afr. j. lab. med. (Online)
Ano de publicação:
2021
Tipo de documento:
Artigo
Instituição/País de afiliação:
Department of Pathology, Johns Hopkins School of Medicine, Johns Hopkins Bayview Medical Center, Baltimore/US
/
ICON Clinical Laboratories, ICON Clinical Research PLC, Farmingdale,/US